Exploring Time-Sensitive Variational Bayesian Inference LDA for Social Media Data

There is considerable interest among both researchers and the mass public in understanding the topics of discussion on social media as they occur over time. Scholars have thoroughly analysed sampling-based topic modelling approaches for various text corpora including social media; however, another LDA topic modelling implementation—Variational Bayesian (VB)—has not been well studied, despite its known efficiency and its adaptability to the volume and dynamics of social media data. In this paper, we examine the performance of the VB-based topic modelling approach for producing coherent topics, and further, we extend the VB approach by proposing a novel time-sensitive Variational Bayesian implementation, denoted as TVB. Our newly proposed TVB approach incorporates time so as to increase the quality of the generated topics. Using a Twitter dataset covering 8 events, our empirical results show that the coherence of the topics in our TVB model is improved by the integration of time. In particular, through a user study, we find that our TVB approach generates less mixed topics than state-of-the-art topic modelling approaches. Moreover, our proposed TVB approach can more accurately estimate topical trends, making it particularly suitable to assist end-users in tracking emerging topics on social media

A systematic analysis of the X-ray emission in optically selected tidal disruption events: observational evidence for the unification of the optically and X-ray selected populations

We present a systematic analysis of the X-ray emission of a sample of 17 optically selected, X-ray-detected tidal disruption events (TDEs) discovered between 2014 and 2021. The X-ray light curves show a diverse range of temporal behaviors, with most sources not following the expected power-law decline. The X-ray spectra are mostly extremely soft and consistent with thermal emission from the inner region of an accretion disk that cools as the accretion rate decreases. Three sources show the formation of a hard X-ray corona around 200 days after the UV/optical peak. The shape of the spectral energy distribution, traced by the ratio ($L_{\rm BB}/L_{\rm X}$) between the UV/optical and X-ray luminosities, shows a wide range $L_{\rm BB}/L_{\rm X} \in (0.5, 3000)$ at early-times, and converges to disk-like values $L_{\rm BB}/L_{\rm X} \in (0.5, 10)$ at late-times. The evolution of the derived physical parameters favors a decrease in the optical depth of a reprocessing layer instead of delayed disk formation to explain the late-time X-ray brightening found in several sources. We estimate the fraction of optically discovered TDEs with $L_{\rm X}\geq 10^{42}$ erg s$^{-1}$ to be at least $40\%$, and find that the X-ray loudness is independent of black hole mass. We combine our sample with those from X-ray surveys to construct an X-ray luminosity function, best fitted by a broken power-law with a brake at $\sim 10^{44}$ erg s$^{-1}$. We show that there is no dichotomy between optically and X-ray selected TDEs; instead, there is a continuum of early time $L_{\rm BB}/L_{\rm X}$, at least as wide as $L_{\rm BB}/L_{\rm X} \in (0.1, 3000)$, with optical/X-ray surveys selecting preferentially, but not exclusively, from the higher/lower end of the distribution. Our findings are consistent with an orientation-dependent and time-evolving reprocessing layer, and support viewing-angle unification models.Comment: 38 pages, 23 figures, submitted to Ap

Hospitalization for acute cerebellitis in children affected by varicella: how much does it cost?

Background Chickenpox is a highly contagious airborne disease caused by the varicella zoster virus. It is generally benign and self-limiting, but it may be responsible of life-threatening complications. Acute cerebellitis (AC) is the most common neurological complication and is associated with prolonged hospitalization in the acute phase (HAP). Aim of the study To estimate the costs of AC HAP in children affected by varicella. Materials and methods We retrospectively reviewed the medical records of a pediatric cohort hospitalized for chickenpox AC over a period of 15 years (from October 2003 to October 2018) and we analyzed acute care costs. For any patient the HAP has been calculated. The final value includes cost of hospital accommodation and management at the Pediatric and Infectious Diseases Unit. To this cost, the price of procedures (imaging, laboratory exams, medical and paramedical evaluations) and medical treatments was added. Results In the study period, 856 children had been hospitalized for varicella. Out of them, 65 met a diagnosis of AC and were included in the study. The hospitalization length was of 10 days (range 3-20 days). The median cost of HAP for each patient was of 5366 euro, with an average annual cost of 23,252 euro. The most significant part of HAP is due to the cost of hospital accommodation and management at the Pediatric Infectious Diseases Unit, which was about euro 537.78 for a single day. Discussion Although AC post-varicella is rare, its HAP cost is not negligible resulting in substantial economic burden. Vaccination would have probably prevented varicella and AC complication, avoiding hospitalization. Conclusions Financial studies are important for evaluate the cost saving in order to influence public funding decisions. Further studies are necessary to investigate the economic burden of the disease

Demoralization in acute coronary syndrome: Treatment and predictive factors associated with its persistence

Background/objective: Although demoralization is associated with morbidity and mortality in cardiac settings, its treatment has been overlooked. The present randomized controlled trial aimed at 1) evaluating the effectiveness of sequential combination of Cognitive-Behavioral and Well-Being therapies (CBT/WBT), compared to Clinical Management (CM), on demoralization among Acute Coronary Syndromes (ACS) patients, at post-treatment and after 3 months; 2) examining ACS patients' characteristics predicting demoralization persistence at 3-month follow-up. Method: 91 demoralized ACS patients were randomized to CBT/WBT (N = 47) or CM (N = 44). Demoralization was assessed with an interview on Diagnostic Criteria for Psychosomatics Research at baseline, post-treatment and 3-month follow-up. Predictors of demoralization maintenance included cardiac parameters, psychological distress and well-being. Results: Compared to CM, CBT/WBT significantly reduced demoralization post-treatment. Somatization (odds ratio = 1.11; p = 0.027) and history of depression (odds ratio = 5.16; p = 0.004) were risk factors associated with demoralization persistence at follow-up, whereas positive relationships (odds ratio = 0.94; p = 0.005) represented protective factors. Conclusions: The study provides preliminary and promising evidence on the benefits of CBT/WBT in treating demoralization in ACS patients. Moreover, ACS patients with somatization or positive history of depression could be at higher risk for developing persistent demoralization

The Eddington ratio-dependent ‘changing look’ events in NGC 2992

We present an analysis of historical multiwavelength emission of the `Changing Look’ (CL) Active Galactic Nucleu (AGN) in NGC 2992, covering epochs ranging from 1978 to 2021, as well as new X-ray and optical spectra. The galaxy presents multiple Seyfert type transitions from Type 2 to intermediate-type, losing and regaining its Hα broad emission lines (BEL) recurrently. In X-rays, the source shows intrinsic variability with the absorption corrected luminosity varying by a factor of ∼ 40. We rule-out tidal disruption events or variable obscuration as causes of the type transitions, and show that the presence and the flux of th Hα BEL is directly correlated with the 2–10 keV X-ray luminosity (L2−10): the component disappears at L2−10 ≤ 2.6 × 1042 erg cm−2 s−1; this luminosity value translates into an Eddington ratio (λEdd) of ∼ 1 per cent. The λEdd in which the BEL transitions occur is the same as the critical value at which a state transition between a radiatively inefficient accretion flow and a thin accretion disk is expected, such similarity suggests that the AGN is operating at the threshold mass accretion rate between the two accretion modes. We find a correlation between the narrow Fe Kα flux and λEdd, and an anticorrelation between full-width at half maximum of Hα BEL and λEdd, in agreement with theoretical predictions. Two possible scenarios for type transitions are compatible with our results: either the dimming of the AGN continuum, which reduces the supply of ionizing photons available to excite the gas in the Broad Line Region (BLR), or the fading of the BLR structure itself occurs as the low accretion rate is not able to sustain the required cloud flow rate in a disc-wind BLR model

Respiratory Syncytial Virus Bronchiolitis in Infancy: The Acute Hospitalization Cost

Introduction: Respiratory syncytial virus (RSV) bronchiolitis is among the leading causes of hospitalization in infants. Prophylaxis with palivizumab may reduce RSV infection, but its prescription is restricted to high-risk groups. The aim of the study is to retrospectively determine acute hospitalization costs of bronchiolitis. Materials and methods: Infants aged 1 month-1 year, admitted to Bambino Gesu Children Hospital, Rome, Italy, with a diagnosis of bronchiolitis from January 1 till December 31, 2017, were included in the study. Results: A total of 531 patients were enrolled in the study, and the mean age was 78.75 days. The main etiologic agent causing bronchiolitis was RSV, accounting for 58.38% of infections. The total cost of bronchiolitis hospitalization was 2,958,786 euros. The mean cost per patient was significantly higher in the case of RSV (5,753.43 +/- 2,041.62 euros) compared to other etiology (5,395.15 +/- 2,040.87 euros) (p = 0.04). Discussion: The study confirms the high hospitalization cost associated with bronchiolitis. In detail, in the case of RSV etiology, the cost was higher compared to other etiology, which is likely due to the longer hospitalization and the more frequent admission to the intensive cure department. Conclusion: This study highlights that bronchiolitis is an important cost item even in a tertiary hospital and that cost-effective interventions targeting RSV are increasingly urgent

Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes.

Immune checkpoints refer to a plethora of inhibitory pathways of the immune system that play a crucial role in maintaining self-tolerance and in tuning the duration and amplitude of physiological immune responses to minimize collateral tissue damages. The breakdown of this delicate balance leads to pathological conditions, including cancer. Indeed, tumor cells can develop multiple mechanisms to escape from immune system defense, including the activation of immune checkpoint pathways. The development of monoclonal antibodies, targeting inhibitory immune checkpoints, has provided an immense breakthrough in cancer therapy. Immune checkpoint inhibitors (ICI), initially developed to reverse functional exhaustion in T cells, recently emerged as important actors in natural killer (NK)-cell-based immunotherapy. Moreover, the discovery that also helper innate lymphoid cells (ILCs) express inhibitory immune checkpoints, suggests that these molecules might be targeted on ILCs, to modulate their functions in the tumor microenvironment. Recently, other strategies to achieve immune checkpoint blockade have been developed, including miRNA exploiting systems. Herein, we provide an overview of the current knowledge on inhibitory immune checkpoints on NK cells and ILCs and we discuss how to target these innate lymphocytes by ICI in both solid tumors and hematological malignancies

Fludarabine, high-dose cytarabine and idarubicin-based induction may overcome the negative prognostic impact of flt3-itd in npm1 mutated aml, irrespectively of flt3-itd allelic Burden

The mutations of NPM1 and FLT3-ITD represent the most frequent genetic aberration in acute myeloid leukemia. Indeed, the presence of an NPM1 mutation reduces the negative prognostic impact of FLT3-ITD in patients treated with conventional “3+7” induction. However, little information is available on their prognostic role with intensified regimens. Here, we investigated the efficacy of a fludarabine, high-dose cytarabine and idarubicin induction (FLAI) in 149 consecutive fit AML patients (median age 52) carrying the NPM1 and/or FLT3-ITD mutation, treated from 2008 to 2018. One-hundred-and-twenty-nine patients achieved CR (86.6%). After a median follow up of 68 months, 3-year overall survival was 58.6%. Multivariate analysis disclosed that both NPM1mut (p < 0.05) and ELN 2017 risk score (p < 0.05) were significant predictors of survival. NPM1-mutated patients had a favorable outcome, with no significant differences between patients with or without concomitant FLT3-ITD (p = 0.372), irrespective of FLT3-ITD allelic burden. Moreover, in landmark analysis, performing allogeneic transplantation (HSCT) in first CR proved to be beneficial only in ELN 2017 high-risk patients. Our data indicate that FLAI exerts a strong anti-leukemic effect in younger AML patients with NPM1mut and question the role of HSCT in 1st CR in NPM1mut patients with concomitant FLT3-ITD

Fludarabine, high-dose cytarabine and idarubicin-based induction may overcome the negative prognostic impact of flt3-itd in npm1 mutated aml, irrespectively of flt3-itd allelic Burden

The mutations of NPM1 and FLT3-ITD represent the most frequent genetic aberration in acute myeloid leukemia. Indeed, the presence of an NPM1 mutation reduces the negative prognostic impact of FLT3-ITD in patients treated with conventional \u201c3+7\u201d induction. However, little information is available on their prognostic role with intensified regimens. Here, we investigated the efficacy of a fludarabine, high-dose cytarabine and idarubicin induction (FLAI) in 149 consecutive fit AML patients (median age 52) carrying the NPM1 and/or FLT3-ITD mutation, treated from 2008 to 2018. One-hundred-and-twenty-nine patients achieved CR (86.6%). After a median follow up of 68 months, 3-year overall survival was 58.6%. Multivariate analysis disclosed that both NPM1mut (p < 0.05) and ELN 2017 risk score (p < 0.05) were significant predictors of survival. NPM1-mutated patients had a favorable outcome, with no significant differences between patients with or without concomitant FLT3-ITD (p = 0.372), irrespective of FLT3-ITD allelic burden. Moreover, in landmark analysis, performing allogeneic transplantation (HSCT) in first CR proved to be beneficial only in ELN 2017 high-risk patients. Our data indicate that FLAI exerts a strong anti-leukemic effect in younger AML patients with NPM1mut and question the role of HSCT in 1st CR in NPM1mut patients with concomitant FLT3-ITD